Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

37.74
BATS BZX Real-Time Price
As of 3:33pm ET
 +0.20 / +0.53%
Today’s Change
20.79
Today|||52-Week Range
37.88
+12.66%
Year-to-Date
No recent news for Enanta Pharmaceuticals Inc.

Today’s Trading

Previous close37.54
Today’s open37.51
Day’s range37.10 - 37.88
Volume4,630
Average volume (3 months)185,842
Market cap$716.4M
Dividend yield--
Data as of 3:33pm ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)-72.37%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-45.13%
P/E ratioNM
Price/Sales5.80
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.05+0.31%
ACRSAclaris Therapeutics...+0.06+0.22%
CYTKCytokinetics Inc-0.52-3.63%
KERXKeryx Biopharmaceuti...+0.17+2.52%
Data as of 3:36pm ET, 06/26/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$88.3M
Annual profit (last year)$21.7M
Net profit margin24.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
CFO, Principal Accounting Officer &
SVP-Finance
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts